NCT06067087View on ClinicalTrials.gov

Prognostic Understanding in ESC (ProgESC Study)

CompletedOBSERVATIONAL
Enrollment

91

Participants

Timeline

Start Date

November 15, 2023

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions
Advanced Cancer
Trial Locations (1)

Unknown

University College Hospital Macmillan Cancer Centre, London

All Listed Sponsors
lead

University College, London

OTHER

NCT06067087 - Prognostic Understanding in ESC (ProgESC Study) | Biotech Hunter | Biotech Hunter